MarketCap
Facebook
X
TelegramViela Bio, Inc. Betriebszyklus 2011-2026 | VIE
Betriebszyklus Jährlich Viela Bio, Inc.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 174 | 177 | 181 | 168 | 161 | 137 | 114 | 121 | 143 | 132 | 135 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 181 | 114 | 149 |
Betriebszyklus anderer Aktien in der Pharmaeinzelhändler
| Name | Betriebszyklus | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AbbVie
ABBV
|
350 | $ 212.69 | 1.56 % | $ 376 B |  USA |
 |
Altimmune
ALT
|
7.85 K | $ 2.99 | -0.99 % | $ 263 M | USA |
 |
I-Mab
IMAB
|
271 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | USA |
 |
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | USA |
 |
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | USA |
 |
Amgen
AMGN
|
282 | $ 351.17 | 0.69 % | $ 189 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - |  Russia |
 |
Adaptive Biotechnologies Corporation
ADPT
|
107 | $ 12.6 | 1.51 % | $ 1.91 B | USA |
 |
ANI Pharmaceuticals
ANIP
|
295 | $ 73.83 | 1.39 % | $ 1.43 B | USA |
 |
BeiGene, Ltd.
BGNE
|
52.6 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Autolus Therapeutics plc
AUTL
|
129 | $ 1.2 | -1.24 % | $ 319 M | Britain |
 |
ChemoCentryx
CCXI
|
3.1 | - | - | $ 3.74 B | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
947 | $ 9.4 | 0.8 % | $ 1.94 B | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
102 | $ 320.53 | 1.0 % | $ 42 B | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
50 | $ 4.33 | 0.82 % | $ 830 M |  Canada |
 |
Biogen
BIIB
|
402 | $ 187.97 | 2.24 % | $ 27.5 B | USA |
 |
Brickell Biotech
BBI
|
254 | - | -5.38 % | $ 6.06 M | USA |
 |
Calithera Biosciences
CALA
|
28.8 | - | -10.95 % | $ 876 K | USA |
 |
Fusion Pharmaceuticals
FUSN
|
6 | - | - | $ 1.41 B | Canada |
 |
Amphastar Pharmaceuticals
AMPH
|
237 | $ 19.27 | 1.37 % | $ 901 M | USA |
 |
Завод ДИОД
DIOD
|
64.6 | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
9.78 | - | - | - | Russia |
 |
BioMarin Pharmaceutical
BMRN
|
733 | $ 54.65 | 0.94 % | $ 10.5 B | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
332 | $ 20.96 | 0.99 % | $ 3.47 B | USA |
 |
Bristol-Myers Squibb Company
BMY
|
153 | $ 59.57 | 1.79 % | $ 121 B | USA |
 |
Benitec Biopharma
BNTC
|
141 | $ 10.23 | -0.39 % | $ 421 M | USA |
 |
Teligent, Inc.
TLGT
|
167 | - | -13.85 % | $ 16.1 M | USA |
 |
Mirum Pharmaceuticals
MIRM
|
70.6 | $ 88.1 | -0.38 % | $ 4.42 B | USA |
 |
Codexis
CDXS
|
70.7 | $ 1.54 | -2.53 % | $ 134 M | USA |
 |
Cerus Corporation
CERS
|
47 | $ 1.79 | 0.56 % | $ 341 M | USA |
 |
Coherus BioSciences
CHRS
|
656 | $ 1.62 | -0.61 % | $ 190 M | USA |